To summarize current approaches for differentiating non-hydrocephalic ventriculomegaly from hydrocephalus using neuroimaging, CSF dynamics, biomarkers, and clinical symptoms.
Approach:
Key Findings:
Accurate differentiation between non-hydrocephalic ventriculomegaly and hydrocephalus is critical to avoid inappropriate management.
Neuroimaging markers and advanced imaging techniques enhance diagnostic performance.
CSF dynamics assessments provide insights into CSF circulatory dysfunction but have limited clinical availability.
CSF biomarkers show potential in distinguishing conditions but require further validation for clinical application.
Symptom overlap complicates the diagnosis, necessitating a comprehensive clinical assessment.
Interpretation:
A multidimensional strategy integrating neuroimaging, CSF dynamics, biomarkers, and clinical symptoms is essential for accurate diagnosis.
Limitations:
No integrated diagnostic gold standard currently exists in clinical practice.
Imaging findings alone are often insufficient for a definitive diagnosis.
Clinical use of CSF dynamic assessments is limited by technical requirements.
Conclusion:
A comprehensive framework for differentiating non-hydrocephalic ventriculomegaly from hydrocephalus may improve diagnostic accuracy and guide clinical management.
